PLN and cardiomyopathy: Compared to gene therapy utilized in earlier studies, these promising results in rodent models of MI, in PLN R14del related cardiomyopathy and DCM (Cspr3/Mlp−/−), highlight the therapeutic potential of targeting cardiac PLN35,44,45.